A diverse array of genetic factors contribute to the pathogenesis of Systemic Lupus Erythematosus

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Tiffin, Nicki ^a   Adeyemo, Adebowale ^b   Okpechi, Ikechi ^c  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Apoptosis; Autoimmunity; Disease genes; dsDNA; Genetic susceptibility; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; DNA; DNA FRAGMENT; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; RNA; STAT PROTEIN; TOLL LIKE RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; CHROMATIN; COPY NUMBER VARIATION; DENDRITIC CELL; DISEASE COURSE; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; ENVIRONMENTAL FACTOR; ETHNICITY; FRAMESHIFT MUTATION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MONOCYTE; NONHUMAN; PATHOGENESIS; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPREGULATION;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871861222     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-2     Document Type: Review

References (86)

1. Systemic lupus erythematosus. Rahman A, Isenberg DA, N Engl J Med 2008 358 9 929 939 10.1056/NEJMra071297 18305268 (Pubitemid 351397092)
2. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK, Genes Immun 2007 8 6 492 502 10.1038/sj.gene.6364408 17581626 (Pubitemid 47365615)
3. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB, N Engl J Med 2003 349 16 1526 1533 10.1056/NEJMoa021933 14561795 (Pubitemid 37255038)
4. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Pathak S, Mohan C, Arthritis Res Ther 2011 13 5 241 10.1186/ar3465 21989039
5. Systemic lupus erythematosus: from genes to organ damage. Kyttaris VC, Methods Mol Biol 2010 662 265 283 10.1007/978-1-60761-800-3-13 20824476
6. Systemic lupus erythematosus in the community: incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Fessel WJ, Arch Intern Med 1974 134 1027 1035 10.1001/archinte.1974.00320240061006 4433183
7. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Danchenko N, Satia JA, Anthony MS, Lupus 2006 15 5 308 318 10.1191/0961203306lu2305xx 16761508 (Pubitemid 43828810)
8. Lupus in the developing world-is it any different? Tikly M, Navarra SV, Best Pract Res Clin Rheumatol 2008 22 4 643 655 10.1016/j.berh.2008.05.003 18783742
9. Systemic lupus erythematosus-an update. Drug Ther Bull 49 7 81 84
10. Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Nightingale AL, Farmer RD, de Vries CS, Pharmacoepidemiol Drug Saf 2006 15 9 656 661 10.1002/pds.1199 16389657 (Pubitemid 44404664)
11. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ, Arthritis Rheum 2007 57 4 612 618 10.1002/art.22683 17471530 (Pubitemid 46764051)
12. Low frequency of autoimmune disease in tropical Africa. Adebajo AO, Lancet 1997 349 9048 361 362 9024407 (Pubitemid 27056847)
13. Rheumatic disease in an Australian aboriginal community in North Queensland Australia. A WHO-ILAR COPCORD survey. Minaur N, Sawyers S, Parker J, Darmawan J, J Rheumatol 2004 31 5 965 972 15124258 (Pubitemid 38585822)
14. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, Ferraz MB, J Rheumatol 2004 31 3 594 597 14994410 (Pubitemid 38337624)
15. Systemic lupus erythematosus in migrants from west Africa compared with afro-caribbean people in the UK. Molokhia M, McKeigue PM, Cuadrado M, Hughes G, Lancet 2001 357 9266 1414 1415 10.1016/S0140-6736(00)04580-3 11356443 (Pubitemid 32455373)
16. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the »prevalence gradient hypothesis» Bae SC, Fraser P, Liang MH, Arthritis Rheum 1998 41 12 2091 2099 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.0.CO;2-D 9870865 (Pubitemid 29009366)
17. Systemic lupus erythematosus: genes versus environment in high risk populations. Molokhia M, McKeigue P, Lupus 2006 15 11 827 832 10.1177/0961203306070007 17153858
18. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG, Proc Natl Acad Sci U S A 2007 104 17 7169 7174 10.1073/pnas.0608889104 17435165 (Pubitemid 47186027)
19. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, et al. Genes Immun 2011 12 4 270 279 10.1038/gene.2010.73 21270825
20. Apoptosis in the pathogenesis of systemic lupus erythematosus. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J, Lupus 2008 17 5 371 375 10.1177/0961203308089990 18490410 (Pubitemid 351798710)
21. Decreased phagocytosis of apoptotic cells in diseased SLE mice. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH, J Autoimmun 2004 22 2 139 145 10.1016/j.jaut.2003.11.003 14987742 (Pubitemid 38252970)
22. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG, Ann Rheum Dis 2006 65 1 57 63 10.1136/ard.2005.035733 15919679 (Pubitemid 41815640)
23. A blast from the past: clearance of apoptotic cells regulates immune responses. Savill J, Dransfield I, Gregory C, Haslett C, Nat Rev Immunol 2002 2 12 965 975 10.1038/nri957 12461569 (Pubitemid 37323217)
24. The danger model: a renewed sense of self. Matzinger P, Science 2002 296 5566 301 305 10.1126/science.1071059 11951032 (Pubitemid 34303674)
25. Developments in the scientific understanding of lupus. Ardoin SP, Pisetsky DS, Arthritis Res Ther 2008 10 5 218 10.1186/ar2488 18947369
26. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, et al. Nat Med 2005 11 2 138 145 10.1038/nm1176 15654326 (Pubitemid 40321348)
27. Toll-like receptors in systemic autoimmune disease. Marshak-Rothstein A, Nat Rev Immunol 2006 6 11 823 835 10.1038/nri1957 17063184 (Pubitemid 44631651)
28. Nucleic acid recognizing Toll-like receptors and autoimmunity. von Landenberg P, Bauer S, Curr Opin Immunol 2007 19 6 606 610 10.1016/j.coi.2007. 10.004 18060756 (Pubitemid 350236814)
29. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. Roth R, Nakamura T, Mamula MJ, J Immunol 1996 157 7 2924 2931 8816398 (Pubitemid 126450048)
30. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS, Mol Cancer Res 2006 4 7 437 447 10.1158/1541-7786.MCR-06-0007 16849519 (Pubitemid 44197039)
31. Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Tveita AA, Rekvig OP, Zykova SN, Kidney Int 2008 74 9 1150 1158 10.1038/ki.2008.308 18596727
32. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL, Am J Med 1975 59 4 533 552 10.1016/0002-9343(75)90261-2 1101680
33. A brief history of twins. Block SR, Lupus 2006 15 2 61 64 10.1191/0961203306lu2263ed 16539274 (Pubitemid 43345328)
34. A revised estimate of twin concordance in systemic lupus erythematosus. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM, Arthritis Rheum 1992 35 3 311 318 10.1002/art.1780350310 1536669
35. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA, Arthritis Rheum 2005 52 4 1138 1147 10.1002/art.20999 15818688 (Pubitemid 40530121)
36. The application of genetic epidemiology to systemic lupus erythematosus. Hochberg MC, J Rheumatol 1987 14 5 867 869 3480955
37. A family survey of lupus erythematosus. 1. Heritability. Lawrence JS, Martins CL, Drake GL, J Rheumatol 1987 14 5 913 921 3430520
38. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Deng Y, Tsao BP, Nat Rev Rheumatol 2010 6 12 683 692 10.1038/nrrheum.2010. 176 21060334
39. Searching for genetic determinants in the new millennium. Risch NJ, Nature 2000 405 6788 847 856 10.1038/35015718 10866211 (Pubitemid 30407863)
40. Meta-analysis in genome-wide association studies. Zeggini E, Ioannidis JP, Pharmacogenomics 2009 10 2 191 201 10.2217/14622416.10.2.191 19207020
41. What can genome-wide association studies tell us about the genetics of common disease? Iles MM, PLoS Genet 2008 4 2 33 10.1371/journal.pgen.0040033 18454206 (Pubitemid 351328518)
42. Guilt beyond a reasonable doubt. Altshuler D, Daly M, Nat Genet 2007 39 7 813 815 10.1038/ng0707-813 17597768 (Pubitemid 47014482)
43. Identification of causal sequence variants of disease in the next generation sequencing era. Kingsley CB, Methods Mol Biol 2011 700 37 46 10.1007/978-1-61737-954-3-3 21204025
44. Genetic analyses of interferon pathway-related genes reveals multiple new loci associated with systemic lupus erythematosus (SLE). Ramos PS, Williams AH, Ziegler JT, Comeau ME, Guy RT, Lessard CJ, Edberg JC, Zidovetzki R, Criswell LA, Gaffney PM, et al. Arthritis Rheum 2011 63 7 2049 2057 10.1002/art.30356 21437871
45. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, et al. Arthritis Rheum 2008 58 1 15 25 10.1002/art.23177 18163481
46. Gene ontology: tool for the unification of biology. The gene ontology consortium. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Nat Genet 2000 25 1 25 29 10.1038/75556 10802651 (Pubitemid 30257031)
47. A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. Zhou J, Wu R, High AA, Slaughter CA, Finkelstein D, Rehg JE, Redecke V, Hacker H, Proc Natl Acad Sci U S A 2011 108 44 998 E1006 10.1073/pnas.1106232108 22011580
48. Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. Yan K, Cao Q, Reilly CM, Young NL, Garcia BA, Mishra N, J Biol Chem 2011 286 33 28833 28843 10.1074/jbc.M111.233932 21708950
49. HDAC inhibition in lupus models. Reilly CM, Regna N, Mishra N, Mol Med 2011 17 5-6 417 425 21327298
50. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Yu HH, Liu PH, Lin YC, Chen WJ, Lee JH, Wang LC, Yang YH, Chiang BL, Lupus 2010 19 10 1219 1228 10.1177/ 0961203310371152 20530519
51. Finding genes that underlie complex traits. Glazier AM, Nadeau JH, Aitman TJ, Science 2002 298 5602 2345 2349 10.1126/science.1076641 12493905 (Pubitemid 36014199)
52. Navigating the HapMap. Barnes MR, Brief Bioinform 2006 7 3 211 224 10.1093/bib/bbl021 16877472 (Pubitemid 44404872)
53. A functional variant in microrna-146a promoter modulates its expression and confers disease risk for Systemic Lupus Erythematosus. Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian XX, Tang Y, Lau YL, De Vries N, et al. PLoS Genet 2011 7 6 1002128 10.1371/journal.pgen.1002128 21738483
54. A comprehensive analysis of common copy-number variations in the human genome. Wong KK, de Leeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman DE, MacAulay C, Ng RT, Brown CJ, Eichler EE, et al. Am J Hum Genet 2007 80 1 91 104 10.1086/510560 17160897 (Pubitemid 46047653)
55. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu Y, Kitzmiller K, et al. Am J Hum Genet 2007 80 6 1037 1054 10.1086/518257 17503323 (Pubitemid 47579341)
56. Complement. First of two parts. Walport MJ, N Engl J Med 2001 344 14 1058 1066 10.1056/NEJM200104053441406 11287977 (Pubitemid 32267977)
57. Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Ptacek T, Li X, Kelley JM, Edberg JC, Cytogenet Genome Res 2008 123 1-4 142 147 19287148
58. Is there a link between dysregulated miRNA expression and disease? Thai TH, Christiansen PA, Tsokos GC, Discov Med 2010 10 52 184 194 20875339
59. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Dai R, Ahmed SA, Transl Res 2011 157 4 163 179 10.1016/j.trsl.2011.01.007 21420027
60. The microRNA world: small is mighty. Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z, Trends Biochem Sci 2003 28 10 534 540 10.1016/j.tibs.2003.08.005 14559182 (Pubitemid 38366279)
61. MicroRNAs of the immune system: roles in inflammation and cancer. Davidson-Moncada J, Papavasiliou FN, Tam W, Ann N Y Acad Sci 2010 1183 183 194 10.1111/j.1749-6632.2009.05121.x 20146715
62. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Wahid F, Shehzad A, Khan T, Kim YY, Biochim Biophys Acta 2010 1803 11 1231 1243 10.1016/j.bbamcr.2010.06.013 20619301
63. microRNAs and the immune response. Tsitsiou E, Lindsay MA, Curr Opin Pharmacol 2009 9 4 514 520 10.1016/j.coph.2009.05.003 19525145
64. MicroRNA in autoimmunity and autoimmune diseases. Pauley KM, Cha S, Chan EK, J Autoimmun 2009 32 3-4 189 194 19303254
65. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB, Lupus 2007 16 12 939 946 10.1177/0961203307084158 18042587
66. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y, Rheumatol Int 2009 29 7 749 754 10.1007/s00296-008-0758-6 18998140
67. Identification of unique microRNA signature associated with lupus nephritis. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, Bruner GR, Harley JB, Ojwang JO, PLoS One 2010 5 5 10344 10.1371/journal.pone. 0010344 20485490
68. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y, Shen N, J Immunol 2010 184 12 6773 6781 10.4049/jimmunol.0904060 20483747
69. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, Iliopoulos D, Boumpas DT, Ann Rheum Dis 2011 70 8 1493 1506
70. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, Yin H, Lu Q, Arthritis Rheum 2011 63 5 1376 1386 10.1002/art.30196 21538319
71. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Lashine YA, Seoudi AM, Salah S, Abdelaziz AI, Clin Exp Rheumatol 2011 29 2 351 357 21385555
72. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus Erythematosus. Hai-yan W, Yang L, Mei-hong C, Hui Z, Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011 33 2 185 188 21529448
73. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, et al. Arthritis Rheum 2009 60 4 1065 1075 10.1002/art.24436 19333922
74. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC, J Rheumatol 2010 37 12 2516 2522 10.3899/jrheum.100308 20952466
75. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. Divekar AA, Dubey S, Gangalum PR, Singh RR, J Immunol 2011 186 2 924 930 10.4049/jimmunol.1002218 21149603
76. Two-step cleavage of hairpin RNA with 5' overhangs by human DICER. Ando Y, Maida Y, Morinaga A, Burroughs AM, Kimura R, Chiba J, Suzuki H, Masutomi K, Hayashizaki Y, BMC Mol Biol 2011 12 6 10.1186/1471-2199-12-6 21306637
77. Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus. Hikami K, Kawasaki A, Ito I, Koga M, Ito S, Hayashi T, Matsumoto I, Tsutsumi A, Kusaoi M, Takasaki Y, et al. Arthritis Rheum 2011 63 3 755 763 10.1002/art.30188 21360505
78. Murine models of systemic lupus erythematosus. Theofilopoulos AN, Dixon FJ, Adv Immunol 1985 37 269 390 3890479 (Pubitemid 15093080)
79. Genetics of SLE: evidence from mouse models. Morel L, Nat Rev Rheumatol 2010 6 6 348 357 10.1038/nrrheum.2010.63 20440287
80. Delineating the genetic basis of systemic lupus erythematosus. Wakeland EK, Liu K, Graham RR, Behrens TW, Immunity 2001 15 3 397 408 10.1016/S1074-7613(01)00201-1 11567630 (Pubitemid 32907387)
81. The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Blake JA, Bult CJ, Kadin JA, Richardson JE, Eppig JT, Nucleic Acids Res 2011 39 Database issue 842 D848 21051359
82. Genetics of systemic lupus erythematosus: contributions of mouse models in the era of human genome-wide association studies. Xu Z, Morel L, Discov Med 2010 10 50 71 78 20670601
83. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, Ahmed SA, PLoS One 2010 5 12 14302 10.1371/journal.pone. 0014302 21170274
84. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Camon E, Magrane M, Barrell D, et al. Nucleic Acids Res 2004 32 Database issue 262 6 14681408
85. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Beissbarth T, Speed TP, Bioinformatics 2004 20 9 1464 5 10.1093/bioinformatics/bth088 14962934 (Pubitemid 38931420)
86. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Zhao X, Tang Y, Qu B, et al. Arthritis Rheum 2010 62 11 3425 35 10.1002/art.27632 20589685